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The bacterial biota of the human vagina can have a profound impact on the health of women and their neonates. Changes in
the vaginal microbiota have been associated with several adverse health outcomes including premature birth, pelvic inﬂammatory
disease, and acquisition of HIV infection. Cultivation-independent molecular methods have provided new insights regarding
bacterial diversity in this important niche, particularly in women with the common condition bacterial vaginosis (BV). PCR
methods have shown that women with BV have complex communities of vaginal bacteria that include many fastidious species,
particularly from the phyla Bacteroidetes and Actinobacteria. Healthy women are mostly colonized with lactobacilli such as
Lactobacillus crispatus, Lactobacillus jensenii,a n dLactobacillus iners, though a variety of other bacteria may be present. The
microbiology of BV is heterogeneous. The presence of Gardnerella vaginalis and Atopobium vaginae coating the vaginal epithelium
in some subjects with BV suggests that bioﬁlms may contribute to this condition.
Copyright © 2008 S. Srinivasan and D. N. Fredricks. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1. INTRODUCTION
The vagina is the Rodney Dangerﬁeld of the human body;
it gets no respect. Although frequently regarded as a mere
passageway for menses, sperm, or neonates, the human
vagina is a highly versatile organ that can profoundly
aﬀect the health of women and their newborn infants. The
environment in the vagina can impact the probability of
conception, the ability to carry a fetus to term, and the
risk of acquiring sexually transmitted diseases such as HIV
infection. Microbes play a critical role in determining the
biochemical and inﬂammatory proﬁle of the vaginal envi-
ronment. Although decades of studies based on cultivation
technologies have illuminated the microbiota of the human
vagina, recent studies employing cultivation-independent
methods have signiﬁcantly increased our understanding of
bacterial diversity in this important niche. This review
will focus on the bacterial biota in the human vagina,
with particular attention paid to studies using nucleic acid
sequence-based approaches. We will highlight the changes
in vaginal bacterial communities that are associated with
the common condition bacterial vaginosis (BV) and will
discuss the challenges to using Koch’s postulates [1, 2]
to assess evidence of causation for fastidious bacteria in
these microbial communities. There are many important
pathogens in the vaginal niche such as Neiserria gonorrhea,
Ureaplasma species, Mycoplasma genitalium, Streptococcus
species, Escherichia coli, Chlamydia trachomatis,a n dTri-
chomonas vaginalis which we will not explore in this review.
Studies of fungal, viral, archaeal, and protistan diversity in
the human vagina are important but will not be the focus
of this review due to the paucity of published molecular
surveys. Studies of the human vaginal microbiome in 2009
are in their infancy. Both metagenomic and whole bacterial
genome sequencing projects are underway to help deﬁne the
collection of microbial genes present in the vagina and to
understandtheircontributiontonormalhostphysiologyand
disease.
The picture that emerges from most studies of the
vaginal microbiota described here is static because it is
based on cross-sectional studies that assess the microbial
constituents at discrete and infrequent time points. How-
ever, microbial communities in the human vagina likely
undergo shifts in the representation and abundance of
key species over time that are inﬂuenced by factors which
may include age of the woman, hormonal ﬂuctuations2 Interdisciplinary Perspectives on Infectious Diseases
(e.g., stage of menstrual cycle, contraception), sexual activity
( e . g . ,t y p e so fs e x u a la c t i v i t i e ss u c ha so r a lo ra n a ls e x
followed by vaginal sex, frequency of sex, number of
sex partners, and the genitourinary tract microbiota of
these partners), underlying health conditions (e.g., diabetes,
urinarytractinfection),useofmedications(e.g.,intravaginal
and systemic antibiotics), intravaginal washing practices
and hygiene. Future studies will beneﬁt from the use of
high throughput technologies that will facilitate measuring
ﬂuctuations in the human vaginal microbiota over time in
longitudinal analyses with more frequent sampling. Current
data suggest that these studies will reveal a highly dynamic
human vaginal ecosystem in many women.
2. THE VAGINAL MICROBIOTA: “NORMAL” VERSUS
BACTERIAL VAGINOSIS
Gram stains of vaginal ﬂuid smears from women without BV
typically show Gram-positive rods, with cultures revealing
a predominance of lactobacilli, particularly Lactobacillus
crispatus and Lactobacillus jensenii [3–5]. Lactobacilli are
believed to promote a healthy ecosystem by producing
lactic acid, hydrogen peroxide, and bacteriocins that have
antimicrobial properties thereby excluding pathogens from
this niche [6]. Lactobacillus iners is an underappreciated
member of the normal vaginal biota, as it does not grow on
Rugosa agar that is typically used to isolate lactobacilli [3].
In contrast, women with the condition bacterial vaginosis
(BV) have loss of many Lactobacillus species (except L. iners)
and acquisition of a variety of anaerobic and facultative
bacteria[7,8].Gramstainsofvaginalﬂuidfromwomenwith
BV show loss of Gram-positive rods and their replacement
with Gram-negative and Gram-variable cocci and rods [9].
Cultures of vaginal ﬂuid from subjects with BV typically
yield Gardnerella vaginalis and a mixture of other bacteria
that may include Prevotella, Porphyromonas, Mobiluncus,
and Mycoplasma species. It is not known whether the
primary event initiating BV is the loss of key lactobacilli
or acquisition of the complex bacterial communities found
in this syndrome; these may be simultaneous processes
(Figure 1). It is also possible that some other factor is the
primary etiological agent, and that the changes in vaginal
microbiota reﬂect a downstream event in the pathogenesis
of BV.
3. BACTERIAL VAGINOSIS
BV is the most common cause of vaginal discharge and a
frequent reason for women to seek medical attention [10].
BV is highly prevalent, aﬀecting ∼10–30% of women in the
United States [11], with higher rates reported in African
American women and women from Sub-Saharan Africa
[12–14]. Although BV is an important medical condition
itself, it is associated with several more serious adverse
outcomes including preterm birth [15], pelvic inﬂammatory
disease [16], and acquisition of HIV infection [17]. Women
with BV may have a malodorous vaginal discharge or local
irritation, but about half of the women with diagnosable BV
have no clear symptoms [18]. Some women do not report
?
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Figure 1: Competing models for the pathogenesis of BV. At least 2
models exist to explain the pathogenesis of BV. The lactobacillus
depletion model suggests that there is a decrease in hydrogen
peroxide producing lactobacilli as the primary event that allows
for the overgrowth of facultative anaerobes resulting in BV. The
primary pathogen model suggests that the entry of facultative
anaerobes causes the displacement of lactobacilli thereby resulting
in BV.
abnormal vaginal discharge, but discharge is nonetheless
noted on examination by a clinician, highlighting that many
women with BV are not aware of their diagnosis or consider
their discharge to be within normal bounds. The high
prevalence of BV and the lack of symptoms in a substantial
fraction of aﬀected women lead to the question whether
BV should be considered a normal variant of the vaginal
microbiota or a disease entity. For women aﬀected by severe
symptomatic BV as manifested by profuse vaginal discharge
and less frequently by local burning or itching, there is little
questionthattheyhaveadisease.Forwomenwithlaboratory
evidence of BV but no symptoms, the disease designation
seems inappropriate, though the condition may still impart
increased risk of adverse health outcomes such as preterm
birth. Antibiotics suchasmetronidazole and clindamycin are
usually eﬀective in treating BV in most subjects, leading to
resolution of symptoms, though rates of relapse are high [19,
20]. Either systemic (usually oral) or intravaginal antibiotics
can be used to treat BV.
Symptomatic BV can be described as a syndrome based
on the presence of a collection of clinical features without
a speciﬁc etiologic agent deﬁned. The diagnosis of BV is
usually made using a series of clinical criteria collected
by a clinician performing a pelvic examination, or by
interpretation of vaginal ﬂuid Gram stains. Amsel clinical
criteria are usually employed for the diagnosis of BV in
the clinical setting because the approach is rapid, but it
does require access to a microscope [18]. At least 3 of 4
Amsel criteria must be present to establish a diagnosis of
BV, including (1) elevated vaginal ﬂuid pH > 4.5; (2) a
positive “whiﬀ test” which consists of the detection of a ﬁshy
odor upon addition of 10% potassium hydroxide to a slide
containingvaginalﬂuid;(3)thepresenceofcluecells(>20%)
in vaginal ﬂuid which are shed vaginal epithelial cells coated
withbacteriacreatingindistinctborders;(4)ahomogeneous,
milky vaginal discharge. Note that it is possible to have a
diagnosis of BV based on Amsel clinical criteria without the
presence of frank vaginal discharge. Accordingly, presuming
that women without vaginal discharge do not have BV isS. Srinivasan and D. N. Fredricks 3
not valid, and studies of the “normal” vagina should ideally
employ an objective method to assess for BV. Unfortunately
there are numerous studies in the ﬁeld that have claimed
thatBV-associatedbacteriaarepartofthenormalmicrobiota
withouthavingassessedforBVstatus,althoughself-reported
vaginal discharge may have been absent. It is possible, indeed
probable, that many BV-associated bacteria can be part of
the normal human vaginal microbiota, but the failure to use
consensus guidelines to deﬁne BV in the research setting is
a recipe for scientiﬁc confusion that is completely avoidable
with well-designed studies.
An alternative method for diagnosis of BV relies on
analysis of Gram stains performed on vaginal ﬂuid smears.
This approach is most commonly employed in the research
setting where Gram stains are used to classify subjects but
is less well suited to the clinical setting because analysis of
the vaginal ﬂuid Gram stains requires a degree of expertise
that is rarely available in real time when the clinician is faced
with the decision whether to treat for BV. For better or for
worse, the vaginal ﬂuid Gram stain is considered the current
diagnostic gold standard as it oﬀers greater reproducibility
and objectivity when compared with the Amsel’s clinical
criteria. For example, there can be variation between tech-
nicians in the evaluation of wet mounts for vaginal clue cells.
Several scoring systems are used to classify vaginal smears.
The method of Nugent et al. [9] assesses the presence and
relative amounts of three bacterial morphotypes, including
Gram-positive rods (lactobacilli), Gram-negative and Gram-
variable rods (Gardnerella vaginalis,a n dBacteroidesspecies),
and curved rods (Mobiluncus species). A Nugent score of 0–3
is considered normal (no BV) and is marked by the presence
of Gram-positive rods, or at least no Gardnerella vaginalis or
Mobiluncus morphotypes. A Nugent score of 7–10 confers
the diagnosis of BV and is marked by the absence of Gram-
positive rods and the presence of high concentrations of
Gardnerella or Mobiluncus morphotypes. A Nugent score
of 4–6 is designated intermediate ﬂora and has Gram stain
features between the two poles. Alternative scoring systems
for interpretation of vaginal ﬂuid Gram stains exist, such as
that of Ison and Hay [21].
4. THE ROLE OF GARDNERELLAVAGINALIS IN BV
In a sentinel paper published in 1955, Herman Gard-
ner and Charles Dukes reported the successful isolation
of a novel bacterium from subjects with the syndrome
nonspeciﬁc vaginitis, now known as BV. The bacterium
was initially named Haemophilus vaginalis but was later
renamed Gardnerella vaginalis. The authors stated, “We are
prepared to present evidence that the vast majority of so-
called “nonspeciﬁc” bacterial vaginitides constitute a speciﬁc
infectious entity caused by a single etiological agent [22].”
These investigators believed that G. vaginalis was the sole
cause of BV and set out to fulﬁll Koch’s postulates for disease
causation in a series of clinical experiments. Pure cultures of
G. vaginalis were inoculated into the vaginas of 13 healthy
women, which resulted in the development of BV in 1 of
the 13, with a corresponding rate of disease production of
7.7%. Based on these data, the investigators concluded that
Koch’s postulates were fulﬁlled, though the 92% failure rate
calls this conclusion into question. The investigators went on
to perform an additional experiment wherein whole vaginal
ﬂuid obtained from subjects with BV was used to inoculate
the vaginas of 15 women without BV. Eleven of these 15
subjects developed BV, yielding a disease induction rate of
73%. The authors felt that these data further supported the
causal role of G. vaginalis in BV because this bacterium
was cultured from most of the induced cases. It is our
interpretation of these studies that whole vaginal ﬂuid is a
much more successful inoculum for the transmission of BV
than is a pure culture of G. vaginalis, suggesting that there
are other factors besides G. vaginalis important in disease
induction.
Other evidence suggests that Gardnerella vaginalis is not
the sole etiological agent in BV. Koch’s postulates demand
that the etiological microbe should be found in every case
of disease but should not be detected in subjects without
disease [1] (see section on Koch’s postulates). G. vaginalis
fails this later test of speciﬁcity because it can be detected
in about 30–50% of women without BV using cultivation
methodsand70%ofwomenwithoutBVusingPCRmethods
[23]. After more than half a century, we are still debating the
role of G. vaginalis in BV. Although G. vaginalis likely plays
an important role in the pathogenesis of BV, it is unlikely
to be the sole instigator because it is never found as the
sole bacterium in vaginal ﬂuid from subjects with BV. Our
hypothesis is that BV is a syndrome caused by communities
of bacteria that include uncultivated species, precluding the
formalapplicationofKoch’spostulatesandnecessitatingnew
approaches for establishing causation.
5. VAGINAL MICROBIAL DIVERSITY:
THE PERSPECTIVE FROM CULTIVATION
With the advent of molecular techniques used to measure
bacterial diversity, it is easy to discount the contributions
from studies based on cultivation because these studies
may fail to detect a large number of fastidious microbes
in any given niche. However, cultivation studies provide
critical insights about the phenotypic characteristics of
microbes that are not easily derived from molecular studies.
Furthermore, cultivated microbes allow for the experimental
manipulation of these organisms in the laboratory and
the testing of hypotheses about pathogenesis and virulence
factors.Accordingly,cultivationstudiesremainanimportant
area of investigation in vaginal microbiology, despite the
limitations of the approach [24]. One reason for pursuing
the combined approach using cultivation and cultivation-
independent methods is that some bacteria are more likely
to be detected by cultivation when present in low concentra-
tions. For example, Verhelst et al. [25] reported that of the
38 vaginal bacterial species identiﬁed from 8 subjects with
and without BV, 5 were detected by cultivation alone. Novel
cultivation approaches may be required to grow the many
fastidious bacterial species found in the human vagina.
Prior to Burton and Reid’s study in 2002 [26], almost
all of our knowledge about the bacteria in the vaginal niche
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organisms by culture on selective or nonselective media
andsubsequentidentiﬁcationbyphenotypictechniques.Just
as use of a variety of broad range bacterial PCR primers
helpstomaximizespeciesdiversity(seesectiononMolecular
Approaches), a number of media and growth conditions
may be needed for the optimal isolation of diverse bacterial
species. Relatively nonselective media such as MacConkey
agar, mannitol salt agar, and tryptic soy base with 5% sheep
blood agar can be useful to estimate numbers of aerobic
and anaerobic bacteria in vaginal samples. Selective or
semiselective media include Rogosa [27]o rd eM a n ,R o g o s a
and Sharpe media (MRS) for lactobacilli and the human
bilayer Tween (HBT) agar for the isolation of Gardnerella
vaginalis [28]. It should be noted that Lactobacillus iners,
presentinmanysubjectswithandwithoutBV,doesnotgrow
on Rogosa agar but can grow on HBT agar.
Cultivation-based approaches have identiﬁed
Gardnerella vaginalis, anaerobic bacteria such as Prevotella,
Porphyromonas, Peptostreptococcus, Mobiluncus,a n d
Mycoplasma to be largely associated with the disturbed
microbiota in subjects with BV. Healthy women are
commonly colonized with hydrogen peroxide producing
lactobacilli which are thought to inhibit the growth of the
fastidious anaerobes associated with BV. Speciﬁc details of
cultivation studies will not be discussed further but can be
obtained from recent reviews [29, 30].
6. VAGINAL MICROBIAL DIVERSITY:
THE MOLECULAR PERSPECTIVE
Cultivation-independent approaches have consistently doc-
umented the high proportion of fastidious bacteria in a
variety of ecological niches [31] and these tools have recently
been applied to study the vaginal ecosystem. Results from
many diﬀerent research groups conﬁrm that the human
vagina hosts numerous bacterial species that are either not
cultivated or not easily identiﬁed using cultivation methods.
These results help to augment, but do not replace, the census
data generated using cultivation-based approaches. Indeed
every method for characterizing the human indigenous
microbiota is subject to some degree of bias. Therefore, it is
our position that the most complete picture of the human
microbiota will emerge from the application and synthesis of
diﬀerent technologies and approaches, including cultivation.
We highlight both the strengths and limitations of various
molecular approaches for describing the vaginal microbiota
below.
The most commonly employed target for molecular
identiﬁcation of bacteria is the small ribosomal subunit
or 16S rRNA gene. The 16S rRNA gene is useful because
it is present in all bacteria and has regions of sequence
conservation that can be targeted with broad range PCR
primers and areas of sequence heterogeneity that can be
used to identify bacteria or infer phylogenetic relationships
(see [32–36]). Once the 16S rRNA gene has been sequenced
from a bacterium, the variable regions can be used for
species-speciﬁc PCR either in a qualitative or quantitative
manner. Quantitative PCR is especially useful for rapidly
identifying bacteria when an internal probe is employed and
for measuring how levels of vaginal bacteria change. Nine
highly variable and therefore phylogenetically rich regions of
the ∼1540 base pair 16S rRNA gene have been described and
designatedV1toV9[37].Thechoiceofprimerstargetingthe
conserved regions ﬂanking the diﬀerent variable regions can
profoundly aﬀect the diversity of bacterial species identiﬁed
[38, 39].
It is theoretically possible to detect every known bacterial
species if suitable broad range PCR primers or combinations
of diﬀerent primer pairs are employed. Current studies
focus on the extraction of total genomic DNA from vaginal
ﬂuid on swabs or from cervicovaginal lavage ﬂuid and
ampliﬁcation of 16S rRNA genes with primers that bind
to conserved sites present in many species. The sequences
obtained are aligned and compared to large databases
of 16S rRNA sequences (http://greengenes.lbl.gov/ [40],
http://rdp.cme.msu.edu/ [41, 42], http://www.arb-home.de/
[43] to infer phylogenetic relationships to known species.
Some studies rely on the construction of clone libraries and
direct sequencing of a particular number of clones [44, 45].
This approach allows for good phylogenetic resolution if a
suitable portion of the 16S rRNA gene is ampliﬁed. However,
this method tends to be expensive, slow, and tedious. Some
investigators try to limit the sequencing of large numbers of
samples by using electrophoretic ﬁngerprinting techniques
such as denaturing gradient gel electrophoresis (DGGE) [46]
or terminal restriction fragment length polymorphism (T-
RFLP) [47]. In the case of DGGE, as the ampliﬁcation
products pass through the denaturing gel, their melting
behavior depends primarily on the length of the product and
the GC content [48]. Typically one of the primers carries
a5  -GC rich clamp, around 40bp, which is used to detect
single-base changes between close products. This clamp
tends to lower the PCR ampliﬁcation eﬃciency and can
increase the presence of PCR artifacts such as heteroduplexes
[48]. T-RFLP involves PCR ampliﬁcation of the community
DNA using primers with ﬂuorescent tags. The resulting
PCR products are digested with restriction enzymes and the
ﬂuorescent terminal restriction products are detected using
a DNA sequencer. The species diversity revealed by DGGE
is much less than the diversity detected by T-RFLP [49],
and this likely reﬂects greater sensitivity of the ﬂuorescence
detectionplatform.Screeningclonesinalibrarybyampliﬁed
ribosomal DNA restriction analysis (ARDRA) in order to
limit the number of clones to be sequencedis also commonly
used. ARDRA is based on the restriction digestion of 16S
rRNA gene clones or ampliﬁed DNA and electrophoretic
separation on high percent agarose or polyacrylamide gels
[7].
An approach complementing broad range PCR is char-
acterization of the vaginal bacterial community by using
nucleic acid probes, oligonucleotides complementary to
rRNA gene targets. Probes are designed using sequences gen-
erated from broad range PCR and sequencing experiments
which can have a wide range of phylogenetic speciﬁcities
ranging from domain to strain levels. There is also a database
maintaining probes designed for many bacteria from other
niches (http://www.microbial-ecology.net/probebase/)[ 50].
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to the clinical samples. Cells are visualized using epiﬂuo-
rescence microscopy in a process referred to as ﬂuorescence
in situ hybridization (FISH). Data can be collected in
both quantitative and qualitative modes. For example, when
ﬂuorescent probes are combined with ﬂow cytometry, one
can rapidly count and collect cells. With confocal scanning
laser microscopy, one can visualize the spatial arrangement
of cells in tissues or body ﬂuids.
7. DIVERSITY STUDIES BASED ON
THE 16S rRNA GENE: LIMITATIONS
While molecular methods have many advantages over cul-
tivation approaches for characterizing microbial diversity,
there are numerous limitations [51–53]. Use of some so-
called “universal primers” targeting conserved regions of
the 16S rRNA gene may not detect all bacteria present in
a sample due to the presence of polymorphic nucleotides
at conserved positions. The primers are more accurately
designated as broad range. Heterogeneity of the 16S rRNA
gene within the same species can also hamper ﬁngerprinting
analysis [39]. Lowering the annealing temperature during
PCR permits mismatches when using broad range primers
thereby increasing the diversity of the PCR products formed,
thoughthismayalsoallownonspeciﬁcampliﬁcationofDNA
f r o mh u m a nt i s s u e s .D e g e n e r a t en u c l e o t i d e sc a nh e l pi n
overcoming the deﬁciency of broad range primers when
polymorphic base positions are encountered but can lead
to lower eﬃciency of primer binding due to exact matches
of variants being diluted in the primer pool. If the primer
concentrations are increased to overcome this dilution
problem, then there is the potential for increased nonspeciﬁc
product formation. Inosine-based primers are an alternative
to degenerate primers [54] but these cannot be successfully
used with Pfu [55], a high ﬁdelity polymerase. One example
of a commonly used broad range PCR primer targeting the
16S rRNA gene is the 27f (8f) primer at the 5  e n do ft h e1 6 S
rRNA gene. This primer has multiple mismatches with many
Chlamydiae and Biﬁdobacteria, highlighting the fact that
this primer may be highly ineﬃcient in detecting bacteria in
these phylogenetic groups [38]. More frequently, individual
species within phylogenetic groups may have mismatches
that result in reduced ampliﬁcation eﬃciencies [30]. Frank
et al. [38] evaluated the 27f (8f) primers (designated as 27f-
CC and 27f-CM) that are commonly used in many broad
range PCR studies and formulated a 27f primer mixture
(designated as 27f-YM+3) that included three sequences not
usually accounted for in many contemporary studies. These
primers are better matches with bacteria in the Chlamydiales
and Biﬁdobacteriales orders as well as bacteria in the Borrelia
genus. Using a combination of linear ampliﬁcation with the
27f formulation and quantitative PCR, they showed that the
formulated primer mixture performed better at detecting
Gardnerella vaginalis sequences even at elevated annealing
temperatures (60
◦C) than the 27f primers typically used in
the literature. Several studies have attempted to characterize
the vaginal bacterial biota using the conventional 27f primer
and these studies appear to underrepresent bacteria such
as G. vaginalis which is a common member of the vaginal
ecosystem [25, 56]. Although use of complex primer mix-
tures may increase the diversity of bacteria detected by broad
range PCR, this advantage comes at a cost. When using the
primer mixture, there is a slight decrease in ampliﬁcation
eﬃciency due to a reduction in primer concentrations with
exact matches.
We have seen similar problems with the 27f primer in
our broad range bacterial PCR studies of the vaginal niche.
We ampliﬁed a region of the ribosomal RNA operon using
27f [57] modiﬁed with one degeneracy (27f-CM) and 189r
[58] at an annealing temperature of 55
◦C. Clone library
analysis on a model subject with BV revealed the absence
of Gardnerella vaginalis (Figure 2, unpublished data). In
contrast, by utilizing a diﬀerent forward primer (338f)
and the same reverse primer, G. vaginalis emerged as the
dominant clonein thelibrary(Figure 2).Moreover,ascanbe
seeninFigure 2,useofdiﬀerentforwardprimersonthesame
vaginal sample results in vastly diﬀering rank abundance
plots. For example, a fastidious bacterium in the Clostridiales
order designated BV-associated bacterium 1 (BVAB1) was
detected using the 338f primer while all three novel bacteria
intheClostridialesorderassociatedwithBV(BVAB1,BVAB2,
BVAB3) were detected with the 27f primer. The 5 most
prevalent clones detected with 338f included sequences
matching G. vaginalis type 1, Atopobium vaginae type 1,
BVAB1, G. vaginalis type 2, and Peptostreptococcus while the
most abundant clones seen with the 27f primer were A.
vaginae type 2, BVAB2, Mobiluncus mulieris,B V A B 1 ,a n d
an Eggerthella-like bacterium. Using both sets of primers,
we detected a total of 22 phylotypes of which 10 were
represented as singleton species (detected as a single clone).
When this is compared with each primer pair alone, we were
able to detect only 15 phylotypes each, including 5 singletons
with the 338f primer and 8 single clones with the 27f primer.
We also noted that the 27f primer in combination with 189r
tended to be biased to A. vaginae, thereby not providing
representative reﬂections of bacterial abundance (Figure 2).
However, we found that creating two clone libraries with
diﬀerent forward primers resulted in detection of more
phylotypes, again highlighting the limitations imposed by
the selection of a single primer pair. Accordingly, we suggest
that using combinations of broad range primers on the
same sample may maximize the diversity of species detected,
though this comes at a cost of additional time and money
expended.
The DNA extraction step is vital to getting a repre-
sentative pool of DNA which will then be used for PCR
ampliﬁcation. Species bias for diﬀerent extraction methods
is well known [59, 60]. Presence of inhibitors in the clinical
samples from blood, mucus, or vaginal products can lead to
failed ampliﬁcation or a reduction in the amount of product.
Ampliﬁcation controls are useful in tracking DNA quality
wherein PCR of speciﬁc target genes such as beta-globin
[23] or the 18S rRNA gene [61] can indicate if the DNA
extracted from human tissues is ampliﬁable. Use of internal
ampliﬁcation controls by adding an exogenous template at
known concentrations to the clinical samples can help in
detectionofsubtlePCRinhibitors[62,63],particularlywhen
performing quantitative PCR analysis.6 Interdisciplinary Perspectives on Infectious Diseases
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Figure 2: Comparison of vaginal bacterial species detected by broad range 16S rRNA gene PCR using two diﬀerent forward primers and the same
reverse primer in one sample. The pie charts show the percentages of clones in each library corresponding to speciﬁc bacterial 16S rRNA gene
sequences obtained using broad range PCR followed by cloning and sequencing in a vaginal sample from a subject diagnosed with bacterial
vaginosis.Dataobtainedusingthe338f(a)primershowsabalancedrepresentationofcloneswhilethedataobtainedusingthe27f(b)primer
is skewed toward Atopobium vaginae. Note the absence of Gardnerella vaginalis clones in the clone library created with the 27f primer. BVAB
denotes bacterial vaginosis associated bacterium.
Another issue with broad range PCR targeting the 16S
rRNA gene is the lack of phylogenetic resolution for some
bacteria, even at the species level. For example, diﬀerent
species within the Enterobacteriaceae have very similar 16S
rRNA gene sequences. Other gene targets oﬀer improved
phylogenetic resolution for some species, such as the sigma
factor rpoB present in just one copy per genome [64–67]. A
downsideofusingrpoBasamarkeristhedearthofsequences
available when compared to the 16S rRNA gene. An alter-
nate option is to examine the internal transcribed spacer
region by ribosomal intergenic spacer analysis to distinguish
closely related strains [68–70]. Here again, sequence and
size heterogeneity can be critical limitations, and databases
(http://egg.umh.es/rissc/) supporting this region are small in
comparison to those supporting 16S rRNA gene sequences.
Correlating the number of 16S rRNA gene copies (and
hence clones) to the number of bacteria is frequently not
possible as diﬀerent bacterial species can have varying
numbers of rRNA gene operons per genome (between 1 and
15) and the exact number is unknown for most species [71–
73]. Bacteria with higher rRNA operon copy numbers will
be excessively represented in a clone library when compared
with bacteria with lower copy numbers, thereby introducing
a bias in the community analysis [74]. Moreover, diﬀerent
bacteria may have varying susceptibilities to lysis based on
the extraction methods being used thus leading to diﬀerent
quantities of bacteria observed in subsequent analysis.
Similarly, false positives can impact community analysis
when targeting the 16S rRNA gene using broad range
primers. Low levels of bacterial DNA may be present
in laboratory or PCR reagents and in DNA extraction
kits. Taq polymerase used for PCR ampliﬁcation can have
contaminating 16S rRNA sequences [75, 76]. A way to
monitor this problem is to include negative controls in everyS. Srinivasan and D. N. Fredricks 7
run of PCR. No template PCR controls allow for detection
of contaminants arising from PCR reagents and the water
being used in every PCR experiment. Additionally, it is
extremelyusefultoincludeextractioncontrolswhereinsham
samples are processed and extracted in the same manner as
the experimental samples. These extraction controls should
be subjected to PCR and analysis of products (such as
cloning/sequencing) alongside samples of interest to identify
any contaminants. Limiting the number of ampliﬁcation
cycles and using high amounts of template DNA also help in
reducing ampliﬁcation of low level contaminants that may
have been introduced during the diﬀerent steps of sample
preparation. An important source of PCR contamination is
from previously ampliﬁed products. This can be managed
by separating pre- and post-PCR working spaces, use of
aerosol ﬁlter pipette tips, and addition of uracil glycosylase
to inactivate previously ampliﬁed PCR products.
The PCR ampliﬁcation step itself can introduce biases
such as skewed representation of a sample based on the
guanosine plus cytosine (G+C) content of the bacterium
[77, 78]. Bacteria with higher G+C content may result
in lower throughputs when compared with bacteria with
lower G+C. PCR enhancing additives such as betaine [79],
dimethyl sulfoxide [80], or formamide [81] are typically
used to equalize the read-through eﬃciencies of the diﬀerent
templates with varying G+C contents while the reducing
environments created by β-mercaptoethanol or dithiothre-
itol [82] seem to provide unspeciﬁed PCR enhancing eﬀects.
PCR enhancers that are commercially available (e.g., Q-
solution from Qiagen, PCR enhancer solution from Invitro-
gen) can be expensive and their composition is not known.
Low cost in-house reagents such as a combination of betaine,
dithiothreitol and dimethyl sulfoxide have been shown to
improve both qualitative and quantitative outputs of PCRs
[83].
PCR artifacts are a well-known limitation when using
the broad range PCR approach. Incorporation of incorrect
nucleotides using Taq polymersase may lead to errors in the
sequence. Heteroduplexes may form when primers become
limiting and/or there is greater template diversity [84, 85].
Use of Pfu polymerase which possesses 3  to 5  exonuclease
proofreading capabilities allows for the correction of mis-
incorporated nucleotides and hence has fewer errors when
compared with Taq polymerase [86]. There are other high
ﬁdelity DNA polymerases that are currently available such as
Vent DNA polymerase isolated from Thermococcus litoralis
and Phusion DNA polymerase which is a Pyrococcus-like
enzyme with a double-stranded DNA-binding domain. One
recommendedstrategytolimitheteroduplexmoleculesprior
to cloning is to reamplify 10-fold diluted PCR product
containing mixed templates in a process referred to as
“reconditioning PCR” [85]. Formation of chimeras [87,
88] needs careful monitoring and identiﬁcation. Chimeric
sequences are PCR artifacts that arise when two or more
phylogenetically distinct sequences become combined into
a single sequence when the polymerase jumps between
templates during extension. Several online tools are available
to detect chimeras such as Bellerophon [89], Mallard[90], or
Pintail analysis [91].
While the broad range 16S rRNA gene PCR approach
provides a good census of the bacteria present in the clinical
sample, no functional genomic information is obtained.
Metagenomic approaches have been applied to environ-
mental samples [92, 93] but are slow to be applied to
the vaginal environment due to lack of whole genome
sequence information for creation of a scaﬀold. There is
presently an NIH-led initiative to sequence whole genomes
from cultivable bacteria from the vaginal niche which will
provide the necessary foundation for metagenomic studies
(http://nihroadmap.nih.gov/hmp/).
8. MOLECULAR STUDIES IN THE VAGINAL NICHE:
A CRITICAL EXAMINATION
With advancing technologies and decreasing costs of
sequencing, there have been many recent additions to our
knowledge regarding the human vaginal microbiota. As
conditions in the vagina may be transient and dependent on
numerousfactors,mostmolecularstudiesoﬀerasnapshot of
the vaginal microbiota under speciﬁc conditions. Moreover,
with diﬀering deﬁnitions of “normal,” it can be diﬃcult to
compare the data across many studies. We present here a
survey of key molecular investigations in the vaginal niche,
highlighting the important contributions and the limitations
of each approach.
Burton and Reid [26] were the ﬁrst investigators to
analyze the microbiota of the vaginal niche using broad
range molecular methods. They applied a combination of
broad range bacterial PCR using primers HDA-1-GC (338f
with a GC clamp) and HDA-2 (515r) and DGGE to vaginal
samples obtained from 20 asymptomatic postmenopausal
women and used Nugent scores to distinguish between
healthy and diseased states. Interestingly, 70% of the women
had intermediate ﬂora or BV as indicated by Nugent score,
suggesting that women with abnormal vaginal ﬂora were
overrepresented in their study compared to the general pop-
ulation. Broad range PCR targeting about 200bp of the V2-
V3variableregionsofthe16SrRNAgeneandDGGEanalysis
showed that subjects with low Nugent scores had only one
to two bands, mainly derived from Lactobacillus species,
while subjects with intermediate ﬂora or high Nugent scores
had zero to four bands representing Gardnerella, Prevotella,
Peptostreptococcus, Bacteroides, Lactobacillus, Streptococcus,
and Slackia species. The detection of Lactobacillus iners in
subjectswithnormalﬂorabyGramstainwasanovelﬁnding.
Genus speciﬁc PCR was also used to monitor the bacterial
species detected by broad range PCR. The strength of this
studyistheutilizationofbothbroadrangeandtaxon-speciﬁc
PCR approaches, but the DGGE method may have limited
the diversity detected.
An important observation from this study [26] is that
diﬀerent subjects with BV had diﬀerent DGGE proﬁles
indicating heterogeneity in the composition of bacterial taxa
in subjects with BV. We have observed similar results using
diﬀerent methods. For example, Figure 3 illustrates the dif-
ferences observed in the composition and number of bacte-
rialphylotypesintwosubjectswithBV.Vaginalsampleswere
subjected to broad range 16S rRNA gene PCR using primers8 Interdisciplinary Perspectives on Infectious Diseases
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Figure 3: The microbiology of BV is heterogeneous. Comparison of rank abundance plots from 2 subjects diagnosed with BV. The charts
show the percentages of clones in each library corresponding to speciﬁc bacterial 16S rRNA gene sequences obtained using broad range
PCR followed by cloning and sequencing. The most prevalent bacterial clones in Subject A include those matching Gardnerella vaginalis,
Prevotella s p .t y p e1 ,B V A B 2 ,Prevotella s p .t y p e2 ,a n dLeptotrichia amnionii. In contrast, the most prevalent clones in Subject B include
BVAB1, Sneathia sanguinegens, Prevotella sp. type 1, candidate division TM7, and Prevotella sp. type 2.
338f and 1407r followed by cloning, sequencing, alignment,
and phylogenetic analysis. The most prevalent phylotypes in
Subject A include Gardnerella vaginalis, Prevotella sp. type
1, BVAB2, Prevotella sp. type 2, and Leptotrichia amnionii.
In contrast, the most prevalent bacterial clones in Subject B
include BVAB1, Sneathia sanguinegens, Prevotella sp. type 1,
Candidate division TM7, and Prevotella sp. type 2, thereby
illustrating the diﬀerences in bacterial phylotypes between
two subjects with BV.
In a subsequent study from these investigators, the same
primers HDA-1-GC and HDA-2 with the same PCR condi-
tions were applied to 6 samples obtained weekly from a 51-
year-old woman with recurrent BV (determined by Nugent
score). Overall, 7 bacterial species were detected including
Klebsiella oxytoca, Serratia fonticola, Citrobacter freundii,
Morganella morganii, Kluyvera ascorbata, Escherichia coli,
and Staphylococcus epidermidis [94]. None of the bacteria
typically associated with the vaginal niche were detected
in this study. Similarly, when the primers HDA-1-GC and
HDA-2 were applied to vaginal samples from a cohort of
34 HIV-seronegative Nigerian women with BV, atypical BV-
associated bacteria were detected by broad range PCR and
DGGE [95]. Surprisingly, of the 34 samples, 10 had only 4
bands, 16 had 3 bands, 6 had 2 bands, and 2 had one band. If
each band corresponds to a single bacterial phylotype, the
bacterial diversity associated with BV in this study is sub-
stantially lower than the diversity detected in other studies
and likely reﬂects the limits of the DGGE method employed.
The dominant organism in 35% of subjects was found to
be Mycoplasma hominis. An uncultured Streptococcus sp. was
found in 24% of the subjects and a bacterium related to
a rainbow trout intestinal bacterium was found in 26% ofS. Srinivasan and D. N. Fredricks 9
subjects. The absence of several prominent BV-associated
bacteria may be related to the choice of primers, although
the authors used the same primers to detect Gardnerella,
Prevotella,Mobiluncus,andAtopobium sp.inapreviousstudy
[26]. The diﬀerent results observed in this study could also
be due to diﬀerences in annealing temperatures: 56
◦Ci n
the earlier study [26]a n d6 0
◦C in the later study [96], or
due to diﬀerences in subject populations. The primers used
in these studies have a 40-mer GC clamp that has been
included for DGGE analysis resulting in primers that are 60
baseslong,whichmaycontributetoineﬃcientampliﬁcation.
Based on the data presented, the authors suggest that the
bacteria associated with BV in Nigerian women are diﬀerent
from those bacteria associated with BV in other populations
of women studied. Additional molecular studies evaluating
the bacterial community associated with BV from a variety
of women representing diﬀerent demographic groups are
required to assess the degree of heterogeneity in vaginal
microbiota among women.
Zhou et al. [45] investigated the bacterial community in
5 “apparently healthy” women. The women were classiﬁed
as healthy using a combination of gynecological exams and
self-reported symptoms, but data on Amsel’s clinical criteria
or vaginal ﬂuid Gram stains were not obtained or provided.
This is a major limitation of this study as many women
with BV are asymptomatic. A 920bp fragment of the 16S
rRNA gene was ampliﬁed using primers 8f, also known as
27f (actual primer sequence not speciﬁed), and 926r and
the products were cloned and sequenced. Between 176 and
250 clones were sequenced from each subject resulting in
2 to 7 bacterial phylotypes per subject. Two subjects had
vaginal bacterial biotas dominated by Lactobacillus crispatus,
while Lactobacillus iners was detected in 3 subjects. These
investigators suggest that three novel taxa were associated
with the healthy vagina including Atopobium vaginae,a
Megasphaera species, and a Leptotrichia species. However,
these bacteria have been associated with BV by other
investigators [7, 25, 26, 97]. As standard objective criteria
were not used for the diagnosis of BV, it is diﬃcult to draw
conclusions from this study about the constituents of the
normal vaginal bacterial biota.
Hyman et al. [44] surveyed the bacteria on the vaginal
epithelium by broad range PCR, clone library construction,
and sequencing approximately 1400bp of the 16S rRNA
gene in 20 premenopausal women who were presumably
healthy. While physical exams were conducted in the clinic
and the women were reported to be asymptomatic, the
authors did not report data on BV status using Amsel’s
clinical criteria or vaginal ﬂuid Gram stains; this is a
signiﬁcant limitation of the study. PCR ampliﬁcation of
the genomic DNA was conducted using the conventional 8f
(27f-CM) and 1492r primers. The forward primer has one
mismatch to Atopobium spp. and the reverse primer also
has poor homology possibly leading to poor representation
of Atopobium spp. in the libraries. One thousand clones
were selected for each subject and sequenced from both
ends using conventional sequencing. Four of the 20 subjects
had only Lactobacillus species with very high sequence
diversity indicating that these vaginal bacteria were not
clonal. Nine subjects had a combination of Lactobacillus spp.
and other bacteria including Biﬁdobacterium, Gardnerella,
and Atopobium. The remaining group of 7 women did not
have any lactobacilli but were colonized with mixed bacterial
populations that include bacteria that have been associated
with BV by other investigators. This study provides a rich
resource of vaginal bacterial 16S rRNA gene sequences in
GenBank, but would have been more useful if additional
clinical and microbiological data had been collected to
exclude women with BV or deﬁne those with the condition.
These investigators detected sequences from some bacteria
such as Pseudomonas and Stenotrophomonas species in clone
libraries that are known PCR contaminants. It would have
been helpful to describe PCR and extraction controls to
prove that these bacteria are arising from the vaginal
epithelium and are not spuriously detected by broad range
PCR.
Verhelst et al. [25] used a combination of cultivation
and molecular techniques to identify vaginal bacteria in 8
subjects of whom 3 had normal ﬂora, 2 had intermediate
ﬂora, and 3 had BV as determined by the Gram stain
method of Ison and Hay [21]. Isolates from culture studies
were identiﬁed using either 16S rRNA gene sequencing
or by evaluating the ﬁngerprinting patterns of the spacer
regions between transfer RNA genes. Broad range PCR with
primers 10f (27f-CC, not including the ﬁrst two bases of
the 27f primer) and 534r was used to amplify a ∼500bp
fragment of the 16S rRNA gene resulting in 854 clones
from the 8 subjects. The clones were analyzed using ARDRA
and clones with unique ARDRA patterns were sequenced
for identiﬁcation of the bacteria. A total of 38 species
were identiﬁed using both approaches, of which 18 were
detected by cloning only, 5 were detected by culture alone.
Healthy subjects had vaginal bacterial biotas dominated
by lactobacilli whereas subjects with intermediate ﬂora or
BV ﬂora had greater bacterial diversity. Atopobium vaginae
and several BV-associated bacteria were detected in a large
number of clones generated from subjects with abnormal
ﬂora. The primers selected for broad range PCR proved to
be a poor match for detecting Gardnerella vaginalis, which
was isolated by cultivation. However, G. vaginalis speciﬁc
PCRshowedthatthisbacteriumwasassociatedwithBV.This
study underscores the importance of using a combination of
approaches to attain a complete picture of vaginal bacterial
diversity and the need to optimize primers for broad range
PCR. The use of Gram stain analysis to evaluate BV status is
commendable.
Fredricks et al. [7] evaluated the bacterial community in
the vaginal niche using broad range PCR with primers 338f
and 1407r amplifying a ∼1000bp fragment from the 16S
rRNA gene. This approach was applied to vaginal samples
from 9 subjects with BV and 8 without BV using Amsel’s
clinical criteria to deﬁne BV in a cross-sectional analysis. In
addition, serial vaginal samples were also obtained from a
limited number of subjects to study the change in bacterial
composition associated with incident, cured, relapsing, and
persistent BV. One hundred clones from each subject were
selected and screened using ARDRA with two restriction
enzymes. Inserts with unique patterns were sequenced.10 Interdisciplinary Perspectives on Infectious Diseases
Women with BV showed a high level of species diversity with
a mean of 12.6 bacterial phylotypes versus women without
BV who had a mean of 3.3 phylotypes per clone library.
Lactobacillus species, particularly Lactobacillus crispatus and
Lactobacillus iners were predominant in women without BV.
L. crispatus was not detected in subjects with BV, although
L. iners was widely prevalent. Other bacteria detected in sub-
jects with BV included Gardnerella vaginalis, Megasphaera,
Leptotrichia, Dialister, Atopobium, and several bacterial vagi-
nosis associated bacteria (BVABs) from the Clostridiales
order. Three novel bacteria from the Clostridiales order
were highly speciﬁc indicators of BV [7]. BVAB1, BVAB2,
and BVAB3 belong to the phylum Clostridium but are not
closely related to any bacteria with known 16S rRNA gene
sequences.AsubjectwithincidentBVhadashiftfromabiota
dominated by lactobacilli to one with increased diversity
including many putative anaerobes. A subject with cured
BV had an increase in lactobacilli clones and a contraction
in species diversity. A subject with relapsed BV had great
diversity on day 0 with BV, followed by a contraction to
predominantly L. iners on day 28 with cure, and then an
expansion of phylogenetically rich microbiota on day 100
with relapse. A subject with persistent BV had a consistently
diverse vaginal biota on days 0, 24, and 64, though there
were some changes in species representation over time. A
limitation of this study is that use of ARDRA to screen clones
for sequencing could have underrepresented the bacterial
diversity observed, as this approach tends to lump together
diﬀerent phylotypes with similar sequences. Moreover, only
100 clones were analyzed per library (or vaginal sample) and
this limited the detection of minority species. In order to
visualizethebacteria,FISHwasperformedonvaginalsmears
targeting each of the novel BVABs. BVAB1 was shown to
be a thin curved rod (Figure 4); BVAB2 appears as a short,
fat rod and BVAB3 is a long, lancet-shaped rod. We have
performed transmission electron microscopy on a vaginal
sample containing high levels of BVAB1 as determined by
broad range PCR with clone library analysis, species-speciﬁc
PCR,andFISHexperiments.Theelectronmicrographsshow
longcurvedbacteriawithatranslucentzoneintheouteredge
ofthecellswhichwepresumetobeBVAB1(Figure 5).Thisis
in contrast to the larger, wider, and homogeneously electron
dense cells observed in a transmission electron micrograph
of Mobiluncus curtisii obtained from a pure culture.
We have further compiled clone library data from
subjects with and without BV (Figure 6). Using broad range
bacterial PCR with 16S rRNA gene primers 338f and 1407r,
1327 clones were sequenced from 13 subjects without BV
(Figure 6(a)). Of the 1327 clones analyzed, 65.4% of the
sequenceswereLactobacilluscrispatusand28.8%represented
Lactobacillus iners clones. The remaining 5.8% of clones
included other bacteria such as Gardnerella vaginalis and
other lactobacilli (Figure 6(a)). These data further validate
that subjects without BV have vaginal bacterial biotas
dominated by lactobacilli. In contrast, analysis of 23 clone
libraries from 17 subjects with BV produced 2577 clones
and demonstrated a very high degree of bacterial diversity
(Figure 6(b)). Each subject with BV had an average of
14 species and the top 12 phylotypes accounted for 89%
Figure 4: Fluorescence image of vaginal ﬂuid from a subject with
BV. Bacteria are shown hybridizing with probes targeting BVAB1
(green) and Mobiluncus (red) and visualized by ﬂuorescence in
situ hybridization (FISH). Other bacteria (blue) are seen with 4 ,6-
diamidine-2-phenylindole, dihydrochloride, (DAPI), which stains
DNA.TheinsetshowsthatMobiluncus(green)islargerthanBVAB1
(red) but has the same curved morphology. (With permission from
D. N. Fredricks, T. L. Fiedler, and J. M. Marrazzo, “Molecular
identiﬁcation of bacteria associated with bacterial vaginosis,” New
England Journal of Medicine, vol. 353, pp. 1899–1911, 2005.)
1μm
(a)
1μm
(b)
Figure 5: Transmission electron micrographs. (a) Electron micro-
graph of vaginal ﬂuid from a woman with bacterial vaginosis and
high concentrations of bacterial vaginosis associated bacterium 1
(BVAB1)showsmanycurvedrodswithanelectrontranslucentzone
at the outer edge of the cell. (b) These cells are diﬀerent from the
larger, wider, and more electron dense curved rods observed in
a pure culture of Mobiluncus curtisii. Both images are at 20000x
magniﬁcation.
of clones sequenced. The remaining 11% of sequences
represented 32 phylotypes. Currently, we do not appreciate
the role of the “long tail” of less prevalent bacteria though
it is likely that they contribute to metabolic and functional
diversity in this niche. Moreover, the diversity of bacteria
observed in women with BV suggests that this may be a
polymicrobial syndrome.
The use of broad range bacterial PCR combined with
cloning and sequencing provides a reasonable estimate of the
diversity of the most abundant bacteria but is an expensive
approach with low throughput. Thies et al. [98]u s e da
combination of broad range PCR ampliﬁcation of the 16S
rRNA gene in combination with T-RFLP ﬁngerprinting toS. Srinivasan and D. N. Fredricks 11
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Figure 6: Summary data of rank abundance plots depicting the bacterial species detected in clone libraries from subjects without BV (A) and
with BV (B) in our studies. Broad range PCR using primers 338f and 1407r along with clone library analysis of 1327 clones from 13 subjects
withoutBVresultedin16phylotypesbeingdetected.Similaranalysisof2577clonesfrom23clonelibrariesfrom17subjectswithBVresulted
in the detection of 44 diﬀerent bacterial species. Vaginal bacterial species are indicated on the x-axis and the numbers of clones are indicated
on the y-axis and above every bar. Subjects without BV have bacterial biotas dominated by lactobacilli while subjects with BV have a diverse
bacterial biota. BVAB denotes bacterial vaginosis associated bacterium.12 Interdisciplinary Perspectives on Infectious Diseases
characterize the vaginal bacterial communities in vaginal
swabs from 50 women with BV and 20 healthy women as
determined by Nugent scoring. The authors propose that
PCR combined with T-RFLP is useful to rapidly assess the
most abundant bacteria and hence can be used as a tool
to screen for BV. Primers for ampliﬁcation included 27f
(27f-CC) and 926r and were labeled at the 5  using 6-
carboxyﬂuorescein (6-FAM) and 4,7,2 ,4 ,5 ,7 -hexachloro-
6-carboxyﬂuorescein (HEX), respectively. The restriction
fragment lengths were determined using an automated
sequencer and the fragments were analyzed using an in-
house software program. Identiﬁcation of the fragments was
veriﬁed by sequencing of the PCR products. A total of 23
phylotypes were detected in the samples from subjects with
BV, with a mean of 6.3 phylotypes per subject (range 2–14)
including Atopobium vaginae, Gardnerella vaginalis, Megas-
phaera sp., Lactobacillus iners, Eggerthella sp. and BVAB1,
BVAB2, and BVAB3. Note that the species richness detected
in subjects with BV in this study was less than that reported
by investigators using diﬀerent molecular approaches. In
concordance with the results obtained in other studies
[7, 44], Mobiluncus sp. was detected in only 2 of the 50
subjects with BV. Only lactobacilli including Lactobacillus
iners, Lactobacillus crispatus group, and Lactobacillus gasseri
group were detected in samples from subjects without BV.
One of the limitations of this ﬁngerprinting approach is
the inability to distinguish between closely related species.
For example, the study authors were unable to diﬀerentiate
betweenMobiluncuscurtisiiandMobiluncusmulierisandalso
between the diﬀerent Prevotella phylotypes. This resolution
problem could account for the low numbers of phylotypes
per subject that was observed in this study. A key strength
of the study is the large number of samples processed from
subjects with/without BV deﬁned by Gram stain.
Ferris et al. [97] PCR ampliﬁed a 300bp portion of
the 16S rRNA gene with broad range primers 1055f and
1392r from vaginal samples obtained from subjects with and
without BV as determined from vaginal ﬂuid Gram stains.
The DNA was subjected to DGGE and bands conﬁrmed as
Atopobium vaginae were identiﬁed in 12 of the 22 subjects
with BV and only in 2 of the 24 control subjects. A. vaginae
was also isolated by cultivation from 2 subjects and was
shown to be metronidazole resistant. In a separate study, A.
vaginae-speciﬁc PCR primers amplifying a 155bp amplicon
were applied to the same study cohort [99]. The speciﬁc
primers further enhanced the detection of A. vaginae in
subjects with BV while this bacterium was not detected
in BV negative subjects leading to the suggestion that A.
vaginae is highly speciﬁc for BV. PCR ampliﬁcation using
universal bacterial primers and T-RFLP studies also showed
a correlation of A. vaginae to BV by Verstraelen et al. [100].
Fredricks et al. [23] used a targeted PCR approach to
detect 17 key vaginal bacteria in a more sensitive fashion
than is possible with broad range PCR. The PCR results were
compared with the current consensus diagnostic methods
for BV in order to determine if a qualitative PCR approach
could be used for the molecular diagnosis of BV. Speciﬁc
primers targeting various regions of the 16S rRNA gene
that are speciﬁc to the bacterial species were designed.
The bacteria were chosen based on clone library data
previously generated [7], their apparent speciﬁcity for BV, or
their novelty. All PCR products were sequenced to conﬁrm
their similarity to the intended target. The primers were
applied to 264 vaginal samples obtained from 81 subjects
with BV and 183 subjects without BV. Bacteria from the
Clostridialesorder,Atopobium,anEggerthella-likebacterium,
Sneathia/Leptotrichia, Megasphaera types 1 and 2, and a
bacteriumfromtheTM7divisionwerehighlyspeciﬁcforBV.
Lactobacillus crispatus was inversely associated with BV with
an odds ratio of 0.02 conﬁrming that it is largely associated
with healthy vaginal ﬂora. Gardnerella vaginalis, typically
associated with BV, was found to have poor speciﬁcity for
BV. G. vaginalis was found in 96% of subjects with BV but
was also detected in 70% of the subjects without BV. The
combination of detecting one of the Clostridiales bacteria
(BVAB2) or Megasphaeratype 1 produced the best sensitivity
and speciﬁcity for PCR diagnosis of BV, regardless of the
gold standard diagnostic criteria employed (sensitivity 99%
and speciﬁcity 89%). This suggests that PCR ampliﬁcation
of key vaginal bacteria can indeed be used for the molecular
diagnosis of BV. However, the approach used here requires
electrophoresis to detect the ampliﬁcation products which
may not be optimal in clinical settings. A better approach
would be to use quantitative PCR that oﬀers real-time results
andtheabilitytoquantifybacteria.Levelsofthebacteriamay
be a better indicator of disease than the presence/absence of
particular species.
Some studies have investigated the utility of quantitative
PCR (qPCR) as a diagnostic tool for BV. Sha et al. [101]
were the ﬁrst group to examine the use of qPCR for the
diagnosis of BV, targeting Gardnerella vaginalis, Mycoplasma
hominis,a n dLactobacillus species using 203 samples from
women with BV (Nugent score 7–10) and 203 samples from
women without BV (Nugent score 0–3). Only 75 of the 203
women with BV by Nugent score were positive by Amsel
criteria. Increasing levels of G. vaginalis and M. hominis and
decreasinglevelsoflactobacilliwereshowntobesigniﬁcantly
associated with BV with a sensitivity and speciﬁcity of 83%
and 78% when compared with Nugent score. The study did
not evaluate women with intermediate ﬂora.
In a subsequent study, Menard et al. [102] also inves-
tigated the association of Gardnerella vaginalis as well as
Atopobium vaginae loads by quantitative PCR and assessed
their utility as a diagnostic tool in 231 samples from 204
women. Nugent criteria were used to assess BV status,
classifying 167 samples as normal ﬂora, 20 samples as BV,
and 44 samples as intermediate ﬂora. They showed that the
combination of the presence of A. vaginae at the DNA level
≥108 copies/mL and G. vaginalis at ≥109 copies/mL had a
sensitivity and speciﬁcity of 95% and 99%, respectively.
However, subjects with intermediate ﬂora were excluded
from this analysis. Unfortunately, the promising results from
this study do not reﬂect how these assays would perform
in a clinical setting where all women are being screened
for BV, including those with intermediate ﬂora on Nugent
score. It would have been helpful to collect data on Amsel
clinical criteria in these women to assess BV status using
an alternative standard to determine the reliability of theS. Srinivasan and D. N. Fredricks 13
molecular approach in all women. Another limitation is the
relatively small number of women with BV (20) in the study.
A smaller validation cohort of 56 women was assessed, of
which 7 were considered to have BV by Gram stain and 10
intermediate ﬂora. Eleven of these 56 women had molecular
criteria for BV. It is not clear if the authors are proposing to
treat all women with intermediate ﬂora for BV when they
have molecular evidence of BV-associated bacteria.
Zozaya-Hinchliﬀe et al. [103] assessed the prevalence
and abundance of uncultivated Megasphaera-like bacteria
in the vaginal niche using quantitative PCR targeting two
Megasphaera phylotypes in a cohort of 41 women. The
subjects were diagnosed by vaginal Gram stains and Amsel’s
criteria. Primers speciﬁcally targeting each type were tested
for cross-reactivity using vaginal clones. Megasphaera type 1
was detected in 76% of the subjects while Megasphaera type
2 was found in 52% of the subjects. Moreover, Megasphaera
type 1 concentrations were higher in subjects with BV (up
to 5 orders of magnitude) than subjects without BV, and this
bacterium was signiﬁcantly associated with BV (P = .0072),
aswasMegasphaeratype2(P = .0366).Phylogeneticanalysis
of sequence data indicated that the Megasphaera phylotypes
form two well-supported clades that do not match sequences
originating from the rumen, gut, or oral environments,
suggesting that these two phylotypes may be speciﬁc to the
vaginal niche.
Current treatment strategies for BV include the admin-
istration of antibiotics either orally or topically. The use of
oral metronidazole for 7 days or vaginal metronidazole for 5
days results in an improvement of symptoms in 83%–87% of
women within 2 to 3 weeks [104, 105]. Similar response rates
are observed with the use of vaginal clindamycin. Vaginal
recolonization rates with lactobacilli are similar with both
antibiotics, as deﬁned by detection of lactobacilli on Gram
stain21–30daysafterstartofantibiotictreatment[106,107].
Although there is response to antibiotics in many women,
persistence or recurrence of the condition occurs in 11%–
29% of women at 1 month [104, 108, 109]. Moreover,
long-term recurrence rates have been shown to be greater
than 70% [19, 110, 111]. Marrazzo et al. [63]i n v e s t i g a t e d
several risk factors for BV persistence one month after
treatment, including the detection of key vaginal bacteria
by species-speciﬁc PCR. Persistent BV was present in 25.8%
of women at the 1-month follow-up visit as determined
by Amsel’s clinical criteria, also conﬁrmed by vaginal ﬂuid
Gram stains. Taxon-speciﬁc PCRs targeting bacterial 16S
rRNA genes were used to detect BVAB1, BVAB2, BVAB3,
Peptoniphiluslacrimalis,Megasphaeratype2,andMobiluncus
curtisii at baseline and 1-month follow-up visits. Data were
analyzed by presence or absence of the bacteria. Atopobium,
Gardnerella vaginalis, Megasphaera type 1, and Lactobacillus
iners were found in ≥96% of subjects at baseline and
therefore, these bacteria were not included in the assessment
of risk factors for persistence. Women with BVAB1, BVAB2,
or BVAB3 at baseline were shown to have a 2–8-fold
increased risk of persistent BV. Likewise, presence of P.
lacrimalis or Megasphaera type 2 at baseline imparted a >3-
fold increased risk of persistent BV. Other risk factors such as
sexualbehaviorscommonlylinkedwithpersistencewerealso
examined but were not associated with persistent BV in this
study. A limitation of this approach is that the persistence
data was based on qualitative detection of bacteria rather
than quantitative analyses. Quantitative PCR would help
determine if the bacterial levels remain unchanged during
antibiotic treatment (antibiotic resistance), or if the levels
decline but bacteria are not eradicated, allowing for a future
relapse. Another limitation of this study is the focus on
women who have sex with women. It is not clear if the same
patterns will hold in heterosexual women with BV.
Oakley et al. [112]p e r f o r m e das y s t e m a t i ca n a l y s i so f
bacterial diversity in women with and without deﬁned BV,
incorporating data from Genbank that included publicly
available 16S rRNA gene sequence data obtained from the
vaginal niche. A total of 969 sequences were aligned and
assigned taxonomic classiﬁcations using the Greengenes 16S
rRNA gene database [113]. The sequences were further
analyzedbasedonself-similarities ratherthanincomparison
with an external database and classiﬁed into operational
taxonomicunits(OTUs)usingtheDOTURsoftwarepackage
[114] at a 97% sequence similarity cutoﬀ,w h i c hi sc o m -
monly used for species deﬁnition [115]. Indeed, subjects
with BV had a much greater diversity of bacteria; at the
97% cutoﬀ, women with BV had three times the number
of OTUs (15OTUs) when compared with subjects without
BV (5OTUs). An interesting observation made in this study
was that even though there was quite a bit of variability
in the bacterial species between diﬀerent subjects with BV,
at the phylum level, the presence of bacteria from Bac-
teroidetes and Actinobacteria was strongly associated with
BV. The authors point out that studies assessing bacterial
diversity in the vaginal niche might be underestimating
the true diversity by labeling bacteria with the NCBI-based
designations that lump bacteria with known species. For
example, sequences classiﬁed as Prevotella using the NCBI
classiﬁcation scheme of the Greengenes classiﬁcation tool
actually represented 21OTUs based on the 97% cutoﬀ using
the DOTUR analytical tool, revealing an unexpectedly high
number of vaginal phylotypes or species in this genus. These
diﬀerent vaginal phylotypes may have diﬀerent functional,
metabolic, and inﬂammatory properties. A limitation of
the study by Oakley et al. [112] is that the Greengenes
NCBI classiﬁcation tool used may assign diﬀerent identities
to the same sequence simply based on sequence length.
For instance, two sequences of 100% identity but diﬀerent
lengths can be designated as either Gardnerella or Biﬁ-
dobacterium. Similarly, two identical Atopobium sequences
diﬀerent only in sequence length can either be Atopobium
or Olsenella. Sequences classiﬁed as Biﬁdobacterium in the
NCBI classiﬁcation scheme of the Greengenes database
were classiﬁed as Gardnerella in the RDP database. This
discrepancy highlights the larger problem of deﬁning bac-
terial nomenclature, which is a continuing challenge for
microbial ecologists. One way of addressing this problem
is to create a database of reference sequences to which all
new sequences from the same niche are submitted. This
would also allow rigorous tracking of novel sequences. As
we develop greater understanding of the ecology of the
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able to use the same taxonomic nomenclature to facilitate
comparisons across studies. For example, there is a human
oral microbiome database that provides cross-referenced
taxonomic and genomic information for approximately 600
species (http://www.homd.org/)[ 116].
Zhou et al. [56] studied vaginal bacterial communities
in Caucasian and African American women in the United
States . They applied T-RFLP analysis to 144 women ranging
equally in ages and racial groups from various locations in
the US. The subjects were classiﬁed as healthy based on
examinations by medical personnel, but again BV status
was not reported using either Amsel clinical criteria or
Gram stain assessment of vaginal ﬂuid. Restriction fragment
pattern analysis resulted in the identiﬁcation of 12 bacterial
communitiespresentinatleast2women,and8communities
present in single subjects. Using broad range 16S rRNA gene
PCR primers 8f (27f-CC) and RD1r [117], 57 clone libraries
were analyzed and ∼6000 clones were sequenced. Phyloge-
neticanalysisofthe16SrRNAgenesequencesobtainedledto
the classiﬁcation of the bacterial biota into 8 “supergroups.”
Five of the 8 supergroups were dominated by lactobacilli,
representing 80% of the women sampled. Supergroup III,
accounting for 16.5% of women sampled, had low levels of
lactobacilli and a diversity of bacteria that multiple other
groups have associated with BV, such as Atopobium vaginae,
bacteria from the Clostridiales order, Megasphaera, Dialister,
Anaerococcus,Finegoldia,Peptostreptcoccus,andEubacterium.
Since objective criteria were not used to assess for BV status
(or were not reported), it is unclear if these subjects had BV
or whether BV-associated bacteria colonized women without
BV in this study. The study authors analyzed whether the
bacterial community “supergroups” were associated speciﬁ-
cally with race. Statistical analysis showed that supergroups
III and VIII (containing a single clade of Lachnospiraceae)
were found more often in African American women. Vaginal
bacterial communities not dominated by lactobacilli were
f o u n di n3 3 %o fA f r i c a nA m e r i c a nw o m e na n d7 %o f
Caucasian women. It is known that African American
women have a higher rate of BV than Caucasian women
[11].Theracialdiﬀerencesinvaginalmicrobiotaof“healthy”
women noted in this study may simply reﬂect the failure
to assess for BV. A substantial fraction of women with
BV are asymptomatic, therefore assessing for BV status
based on self-report of symptoms, as done in this study,
is unreliable. Nevertheless, the fact that African American
women have a higher prevalence of BV and therefore tend
to have more diverse vaginal bacterial communities begs
for an explanation. Strengths of the paper include the large
numberofsamplesprocessed,theuseofT-RFLPtoscreenfor
community types, and rigorous statistical analyses applied.
Limitations are the lack of objective diagnostic criteria
for BV and use of a 27f primer for broad range analysis
with poor homology to some vaginal bacteria that may
account for the almost negligible abundance of Gardnerella
vaginalis detected. The meaning of bacterial community
“supergroups” is diminished when key members of the
vaginal bacterial community are underrepresented, though
this is a problem that is shared by all studies using broad
range PCR to some degree.
One study assessed the vaginal microbiota from 16
women without BV (assessed by Nugent score <4), using
a PCR-based approach targeting the chaperonin-60 gene
(cpn60) [118]. Chaperonin-60 is present in all bacteria and
is required for the folding and assembly of proteins and
protein complexes. Most subjects were colonized largely
with lactobacilli including Lactobacillus crispatus, Lactobacil-
lus gasseri, Lactobacillus jensenii,a n dLactobacillus iners.
Other sequences identiﬁed included those with similarity
to Gardnerella vaginalis, Porphyromonas spp., Megasphaera
spp, and Chlamydophila psittaci. This is the only study that
has examined the diversity of bacteria in the vaginal niche
using a diﬀerent target gene. This study provides a nice
corroboration of results from studies using the 16S rRNA
gene as a target, wherein lactobacilli have been shown to
dominate the bacterial biota in subjects without BV. The
detection of C. psittaci as part of the normal vaginal ﬂora is
interestingandrathersurprisingsincethisChlamydiaspecies
is considered a respiratory and zoonotic pathogen and has
not been previously detected in the human vagina, though
it has been detected in the ovine vagina. Using a diﬀerent
target gene oﬀers a diﬀerent perspective on the constituents
of a microbial community. However, the limited database
of cpn60 gene sequences may hinder accurate bacterial
identiﬁcation and the generation of phylogenetic inferences.
9. PYROSEQUENCING: A HIGH THROUGHPUT
SEQUENCING APPROACH
While conventional sequencing techniques have provided us
with a framework, the true extent of bacterial diversity in the
vaginal niche is poorly understood. Analysis of the sequence
datafrom100even1000clonesresultsinalibrarywithalong
tail of many phylotypes detected as singlet clones when the
dataisrepresentedinrankabundanceplots.Basedonculture
techniques, it is estimated that the density of vaginal bacteria
per gram of vaginal ﬂuid ranges up to 108 colony forming
units [119]. If a subject has 108 bacteria/gm of vaginal ﬂuid
and 100 clones are characterized, bacteria present at 106
CFU or below are less likely to be included in the analysis.
Moreover,classicalclonelibraryanalysistendstoprovideless
emphasis to the long tail of minority species [51]. In fact, the
census of bacteria present at low concentrations may provide
important details about genetic and functional diversity in
this niche [51, 120, 121]. This is especially relevant in a
syndrome such as BV where we still do not understand the
pathogenesis of infection.
An alternate approach for obtaining large numbers of
sequences is by using pyrosequencing technology. Pyrose-
quencing is a “sequencing by synthesis” method which
involves taking a single strand of DNA to be sequenced and
sequencing the complementary strand enzymatically while
monitoring the photons generated with the addition of each
base [122]. The technology was applied on a small scale level
to identify isolates by analyzing the signature sequences of
the V1 and V3 regions of the 16S rRNA gene in 96 well plates
[123, 124]. A disadvantage of the early approach was the
very short read lengths obtained (25 to 100 nucleotides long)
limiting accurate phylogenetic classiﬁcation.S. Srinivasan and D. N. Fredricks 15
Currently, pyrosequencing technology has been further
developed and it is now possible to achieve longer reads
of 250 to 300bps in a throughput of 400000 reads per
7.5 hour run which can generate over 100 million bases
(Genome Sequencer FLX System—454 Life Sciences). The
extracted DNA from the vaginal sample can be ampliﬁed
using fusion broad range primers (modiﬁed with adaptor
sequences) targeting the variable regions of the 16S rRNA
gene. The PCR products with the adaptor sequence are
attached to microscopic capture beads. Emulsion-based
clonal ampliﬁcation (emPCR) can create several copies of
the target 16S rRNA gene sequence per bead without the
need for cloning the sequences into bacteria. The beads
are then transferred to a picotitre plate for sequencing.
Pyrosequencing technology has been used for microbial
community analysis in a variety of environments [125–130].
Sundquist et al. examined the bacterial biota in vaginal
samples from 6 pregnant women in all three trimesters
of pregnancy using broad range bacterial PCR with deep
pyrosequencing [129]. Most of the bacterial 16S rRNA gene
was ampliﬁed by PCR and portions of the gene were then
subjected to pyrosequencing. A total of 100000 to 200000
sequence reads of about 100bp average length were obtained
for each of the 6 samples. Each read was processed using
the BLAT tool, a BLAST-like alignment tool [131], and a
database of bacterial sequences obtained from RDP and
archaeal sequences from prokMSA. Two major roadblocks
were faced by the study investigators. First, the short read
lengths made it challenging to assign phylogeny to the
sequence reads. For example, while 90% of the reads were
identiﬁed to the domain level, less than 10% were identiﬁed
to the species level. Only about 50% of sequences were
unambiguously assigned to the class level, and this was likely
due to the ampliﬁcation of both conserved and variable
regions of the 16S rRNA gene, limiting phylogenetic reso-
lution. The authors also performed simulation calculations
and showed that increasing sequence read lengths up to
800bp had signiﬁcant impacts on phylogenetic assignments.
Current 454 technology allows a read length of 250bp
with 400bp reads on the horizon or in place at the time
of this review. The second challenge encountered by the
investigators was the lack of sequences in public databases
resulting in many bacteria being classiﬁed as “unknown.”
This problem will improve with time as more sequences are
added to the databases. In accordance with data obtained
from conventional cloning and sequencing experiments, the
Sundquist study showed that subjects were largely colonized
with lactobacilli, with a variety of other bacteria at lower
concentrations including some such as Comamonas.I no u r
hands, Comamonas spp. are common PCR contaminants
that are typically present in water samples. As the study
did not report results from negative controls such as sham
DNA extractions with PCR and subsequent pyrosequencing,
it is diﬃcult to evaluate if Comamonas is indeed a part
of the vaginal bacterial biota. It is imperative to conduct
appropriate negative controls especially for pyrosequencing
studies as the technique involves deep sequencing and can
therefore easily pick up contaminating sequences even at low
concentrations.
(a) (b)
Figure 7: V a g i n a lb i o p s yf r o mas u b j e c tw i t hB V .A Gardnerella
vaginalis bioﬁlm (yellow) is detected at the edge of the vaginal
epithelium (bottom) by ﬂuorescence in situ hybridization (FISH).
The yellow color is the result of using a combination of probes
targeting G. vaginalis (Red), all bacteria (Eub338, green), and 4 ,6-
diamidine-2-phenylindole, dihydrochloride (DAPI, blue) which
stains DNA. Note human cell nuclei in blue. The image on the right
shows a vaginal epithelial cell with a cluster of G. vaginalis breaking
oﬀ the epithelium and likely forming a clue cell.
10. BACTERIAL VAGINOSIS: A BIOFILM SYNDROME?
Bioﬁlms are strongly associated with human infections
and up to 65% of infections treated by physicians in the
developed world have been attributed to bioﬁlms [132,
133]. There is emerging new evidence that bioﬁlms are
associated with BV [134] and it has been suggested that
this bioﬁlm may be critical in pathogenesis. Swidsinski et
al. [134] demonstated the presence of adherent bacterial
bioﬁlms in 90% of subjects with BV while only 10% of
subjects without BV exhibited a similar bioﬁlm. Adherent
bioﬁlms were deﬁned as lawns of bacteria that were tightly
attached to the vaginal epithelial surface and contained
speciﬁc bacterial groups. Biopsies collected from women
with and without BV were sectioned and ﬁxed for FISH and
hybridized with a variety of bacterial rRNA-targeted probes.
Typically, subjects with BV had an adherent bioﬁlm that
wasprimarilycomposedwith3bacterialgroups:Gardnerella
vaginalis was present in 60 to 90% of the bioﬁlm mass,
Atopobium accounted for 1 to 40% of the bioﬁlm mass, and
lactobacilli were present between 1 to 5% in only 20% of the
biopsy samples. Subjects without BV either had no bioﬁlms
with only a few lactobacilli scattered sporadically or had a
loose bacterial bioﬁlm which did not have any particular
structure and was mainly composed of Lactobacillus species.
Preliminary data from our laboratory also indicates
the presence of adherent bioﬁlms in subjects with BV
(Figure 7). Biopsies obtained from women with and without
BV were ﬁxed in alcoholic formalin, sectioned and examined
using FISH with a suite of bacterial rRNA-targeted probes
and 4 ,6-diamidino-2-phenylindole (DAPI), a DNA binding
ﬂuorescent stain. Our data also suggests the presence of a
G. vaginalis bioﬁlm in women with BV (Figure 7) while
subjects without BV did not have a bioﬁlm but had scattered
Lactobacillus species.
More recently, Swidsinski et al. evaluated the eﬀect of
oral metronidazole on the BV bioﬁlm [135]. A cohort of
18 subjects with BV, diagnosed by Gram stains and Amsel
criteria, were treated with oral metronidazole for 1 week.16 Interdisciplinary Perspectives on Infectious Diseases
Subsequently, follow up assessments were conducted at 1-
week intervals for 5 weeks, with 3 subjects representing
each point in time. Vaginal biopsies were examined using
FISH probes targeting all bacteria or speciﬁc bacteria
such as Gardnerella vaginalis, Atopobium, Lactobacillus spp.,
Bacteroides/Prevotella,a n dEnterobacteriaceae. Although, all
subjects studied were considered cured of BV at the end of
the antibiotic therapy, vaginal biopsies revealed a persistent
bioﬁlm. During antibiotic therapy, the bioﬁlm could be
visualized with DAPI (a DNA stain) but had poor uptake
of FISH probes targeting rRNA suggesting that the bacteria
were not actively metabolizing. However, at the end of 5
weeks, an actively metabolizing adherent bacterial bioﬁlm
was detected which primarily consisted of G. vaginalis and
Atopobium sp. [135]. Clinically, recurrence of BV was not
documented due to the limited follow-up time in the study.
Importantlimitationsofthisstudy,alsonotedbytheauthors,
include the small sample size and lack of baseline data.
Furthermore,thedatasetwastreatedasalongitudinalcohort
but each time point represented a group of 3 diﬀerent
subjects. Despite these limitations, this study represents a
novel approach to understanding the pathogenesis of BV.
Bacteria in bioﬁlms respond diﬀerently to antibiotic
treatment when compared with their planktonic counter-
parts [132, 136–138], and antibiotic resistance is postulated
as one of the reasons for persistent and recurrent BV.
A study has shown that planktonic Gardnerella vaginalis
are more sensitive to hydrogen peroxide (5-fold) and
lactic acid (4–8-fold) than G. vaginalis bioﬁlm bacteria,
highlighting the physiological diﬀerences that exist in the
same organism under diﬀerent growth conditions [139].
Several explanations are provided in the literature for the
tolerance to antimicrobials by bioﬁlm bacteria including
reduced penetration of the antimicrobials within the bioﬁlm
and alterations in the stress physiology of the bioﬁlm
bacteria (reviewed in [140]). In order to circumvent issues
of antibiotic resistance in bacterial bioﬁlms, one study has
used a probiotic approach to attempt clearance of the G.
vaginalis bioﬁlm [141]. G. vaginalis bioﬁlms grown in vitro
were displaced with Lactobacillus reuteri RC-14 and to a
limited extent with Lactobacillus iners, commonly found in
the vaginal niche. Future studies evaluating the structure
and composition of bioﬁlms in BV will become critical in
understanding the pathogenesis of this common condition.
11. BEYOND KOCH’S POSTULATES: MOLECULAR
GUIDELINES FOR CAUSATION
RobertKochandhisstudentselaboratedaseriesofpostulates
to determine which microbes caused diseases and which
microbes were colonizers without a direct etiological role
(Table 1, Koch’s postulates). The birth of modern micro-
biology in the latter half of the 19th century necessitated
a system to gauge evidence of causation concordant with
the discovery of numerous human and animal associated
microbes through laboratory propagation. These guidelines,
later called Koch’s postulates, are elaborated in Koch’s paper
“On the Etiology of Tuberculosis” where he beautifully lays
out the foundation for his thinking. Robert Koch was a
Table 1: Koch’s postulates [1].
The etiologic microbe should be found in every case of the disease
The etiologic microbe should not be found in subjects without
disease (speciﬁcity)
The etiologic microbe should be isolated in pure culture on lifeless
media and be capable of causing the characteristic disease anew
upon inoculation in a susceptible host
The etiologic microbe should be reisolated from the experimentally
inoculated host.
Table 2: Limitations of Koch’s postulates.
Ignore the contribution of host, vector, and environment to disease
susceptibility/response
Colonization state (e.g., +PPD skin test for tuberculosis in the
absence of disease) violates Koch’s second postulate
Many pathogens cannot be propagated on lifeless (cell-free)
medium in the lab; these pathogens cannot fulﬁll Koch’s third
postulate
Viruses, parasites, uncultivated bacteria may not grow in pure
culture
Host range restriction of pathogens
Do not consider the possibility of disease produced by a microbial
community rather than a single pathogen
Not completely speciﬁc
prescient giant of microbiology whose thinking has served us
wellthroughmorethanacenturyofuse.However,thepower
of Koch’s postulates arises not from their rigid application,
but from the spirit of critical judgment that they foster.
The esteemed researcher Edward Rosenow provided
evidence that a streptococcus was the cause of poliomyelitis
by fulﬁlling Koch’s postulates [142–144], only to have this
theory overturned with the discovery of poliovirus decades
later. The lack of speciﬁcity demonstrated by Rosenow’s
false attribution of causation to streptococci in the case
of polio highlights only one of many possible limitations
of Koch’s postulates that have emerged after more than a
century of reﬂection (Table 2). These limitations do not
seriously undermine the generally highly speciﬁc ability of
Koch’s postulates to identify true pathogens. If a pathogen
fulﬁlls Koch’s postulates then it is most likely the cause of
the disease, though these results need to be reproducible
and consistent. In the case of Gardnerella vaginalis and BV,
the ability of a pure culture of G. vaginalis to produce BV
in 1 of 13 inoculated subjects is not a very compelling
argument for causation without a better explanation for
the 92% failure rate (see Section 4). Taken to its logical
extreme, the successful induction of AIDS in 1 of 1000
subjects inoculated with Mycoplasma would also not “fulﬁll”
Koch’s third postulate for the role of Mycoplasma in AIDS
in any meaningful or rigorous fashion. Nevertheless, the
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of microbes is the most powerful single approach for
establishing a causal connection between a microbe and a
disease. On the other hand, the failure to fulﬁll Koch’s third
postulate does not mean that a microbe is not the cause
of a disease. Koch’s postulates have excellent speciﬁcity for
causation, but poor sensitivity. For example, many microbes
have not been successfully propagated in pure culture in the
laboratory; these microbes cannot fulﬁll Koch’s postulates as
originally deﬁned. The historical evolution in thinking about
causation and Koch’s postulates is described elsewhere [1, 2].
12. A MOLECULAR VERSION OF KOCH’S POSTULATES
A major limitation of Koch’s postulates is the failure to
account for the possibility that uncultivated microbes play
a role in disease. The use of molecular methods to charac-
terize microbial diversity in many niches has revealed that
cultivated species constitute a minority of microbes in many
ecosystems, including in the human body. Many potential
pathogens can be readily detected using molecular methods
such as PCR. Koch’s postulates can be directly translated into
molecular versions, as follows.
(1) The etiologic microbe or its nucleic acid sequences
should be found in every case of disease. This implies
that the microbe (or its products) is a sensitive
indicator of disease.
(2) The etiologic microbe or its nucleic acid sequences
should not be found in subjects without disease. This
implies that the microbe is a speciﬁc indicator of
disease.
(3) Experimental manipulation of infection through
factors such as antimicrobial agents or induction of
immune responses should demonstrate that changes
inlevelsofanetiologicmicrobecorrelatewithdisease
state in the host.
13. DISEASE BY MICROBIAL COMMUNITY
There are some disease syndromes that may be caused
by consortia of microbes rather than single pathogens.
Examples of these polymicrobial syndromes are gingivitis,
periodontitis, and BV. Proving that a single cultivated or
uncultivated microbe is the cause of a disease can be
challenging.Provingthatamicrobialconsortiumisthecause
of a disease is even more daunting.
Microbes probably exist in communities in order to take
advantage of syntrophic relationships wherein the metabolic
end product of one species is the energy source for a second
species. If critical members of the community are lost, then
the metabolic networks collapse and all members of the
community may suﬀer. However, functional redundancy
amongmicrobesmaymeanthatbacteriumAisnotnecessary
for community health as long as bacterium B is present
withitsoverlappingmetaboliccapacity.Whatdoesthismean
if bacteria A and B are part of a pathogenic community?
It means that neither bacterium will be deemed necessary
for disease, because subjects may have disease when lacking
bacterium A or B, though subjects will not have disease
if lacking both bacteria. Bacteria A and B are considered
suﬃcient when part of the larger community, but not
individually necessary for establishing the community and
producing condition. To address this issue, we will need
to assess not only the species composition of pathogenic
microbial communities, but also the metabolic capabilities
and interdependencies of these communities. Studies of the
humanmicrobiomewillbevitalinﬁllingthisknowledgegap.
14. CONCLUSIONS
In the last two decades, there has been a dramatic increase
in our understanding of the bacterial biota in a variety
of ecological environments using cultivation-independent
molecular methods. These methods have recently been
applied to the human vaginal microbial ecosystem, adding
substantial data on bacterial diversity in this niche. Subjects
without BV have bacterial biotas that are less complex
and are dominated by Lactobacillus species. Subjects with
BV have loss of Lactobacillus crispatus and acquisition of
more complex vaginal bacterial communities that include
many heretofore-uncultivated species. Data emerging from
molecular investigations suggest that it is possible to develop
a PCR-based strategy for the diagnosis for BV. BV may be an
example of a condition produced by a pathogenic microbial
community rather than a single pathogen, presenting many
challenges for understanding the etiology and pathogenesis
of this syndrome. A molecular version of Koch’s postulates
is presented for collecting evidence of causation for unculti-
vated microbes such as those linked to BV. There is new evi-
dence suggesting that BV may be a bioﬁlmcondition in some
women, which may contribute to poor treatment responses
and high relapse rates. Understanding the bacterial biota
of the human vagina is critical for optimizing reproductive
health, and although many advances have been made, there
is much that is unknown about how bacterial communities
in the human vagina promote health and facilitate disease.
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